share_log

Bellerophon Therapeutics' New Phase 3 Trial Size for Lung Disorder Drug Gets US FDA Nod; Shares Rise

Bellerophon Therapeutics' New Phase 3 Trial Size for Lung Disorder Drug Gets US FDA Nod; Shares Rise

贝勒罗芬治疗公司治疗肺部疾病药物的新3期试验规模获得美国FDA批准;股价上涨
MT Newswires ·  2022/09/27 11:06

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发